Congress Summaries

00_ASH2022_MtgReport_Jan18_2022.pdf

Updates from ASH 2022: Updates on the Treatment of CLL

01_ASH2021_Jan09_22.pdf

Highlights for ASH 2021: Updates on the Treatment of CLL

ASCO2021_Summary_Final.pdf

Highlights for ASCO & EHA 2021: Updates on the Treatment of CLL

ASH_Report_Jan15_21.pdf

Updates from the ASH 2020 annual meeting: practice-changing studies in CLL

impact medicom, medical communications, medical writing

Highlights from ASCO 2020: updates on the treatment of CLL

impact medicom, medical communications, medical writing

Updates from the ASH 2019 annual meeting: practice-changing studies in treatment-naïve CLL

impact medicom, medical communications, medical writing

Updates from the 2019 ASCO and EHA annual meetings: a Canadian perspective on high-risk cytogenetics in MM

impact medicom, medical communications, medical writing

Updates from the 2017 ASH annual meeting: practice-changing studies in relapsed and refractory MCL

Tel. 416-434-8923

Email. info@impactmedicom.com